A MYC-rearrangement is a negative prognostic factor in stage II, but not in stage I diffuse large B-cell lymphoma
MYC基因重排是II期弥漫性大B细胞淋巴瘤的不良预后因素，但并非I期弥漫性大B细胞淋巴瘤的不良预后因素。
期刊:Blood Cancer Journal
影响因子:11.6
doi:10.1038/s41408-023-00971-y
de Jonge, A V; Bult, J A A; Karssing, D F E; Nijland, M; Chamuleau, M E D; Brink, M
